Microbot Medical
MBOT
24 hedge funds and large institutions have $1.95M invested in Microbot Medical in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.
4,967% more capital inflows, than outflows
Capital inflows: $782K | Capital outflows: $15.4K
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
9% more funds holding
Funds holding: 22 → 24 (+2)
0.59% more ownership
Funds ownership: 0% → 0.59% (+0.59%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$257K |
| 2 |
BlackRock Institutional Trust
San Francisco,
California
|
+$213K |
| 3 |
Renaissance Technologies
New York
|
+$128K |
| 4 |
Virtu KCG Holdings
New York
|
+$60.3K |
| 5 |
BlackRock Fund Advisors
San Francisco,
California
|
+$29.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8K |
| 2 |
Goldman Sachs
New York
|
-$6K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$913 |
| 4 |
Morgan Stanley
New York
|
-$261 |
| 5 |
IFP Advisors
Tampa,
Florida
|
-$130 |
MBOT Hedge Fund Activity: Q3 2016 in Review
24 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2016, worth a combined $1.95M — up 636% from $265K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MBOT positions and 5 closed out — a net gain of 2 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $257K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $8K sold.
- 24 institutional investors held Microbot Medical (MBOT) as of Q3 2016, up from 22 in Q2 2016.
- Funds reported $1.95M of Microbot Medical stock for Q3 2016, up 636% quarter-over-quarter.
- 7 funds opened new Microbot Medical positions in Q3 2016 and 5 closed out, a net change of +2 holders.
- The largest Microbot Medical buyer in Q3 2016 was D.E. Shaw & Co, an estimated $257K added.
- The largest Microbot Medical seller in Q3 2016 was Susquehanna International Group, an estimated $8K sold.
Based on aggregated 13F filings for Q3 2016.